Serum Levels of Infliximab and Anti-Infliximab Antibodies in Brazilian Patients with Crohn’s Disease

OBJECTIVES: The aim of this study was to evaluate the quantitative serum level of infliximab (IFX) as well as the detection of anti-infliximab antibodies (ATIs) in patients with Crohn’s disease (CD). METHOD: Forty patients with CD under treatment at a tertiary center in southeastern Brazil were eva...

Full description

Bibliographic Details

Published in:	Clinics
Main Authors:	Luis Eduardo Miani Gomes, Francesca Aparecida Ramos da Silva, Lívia Bitencourt Pascoal, Renato Lazarin Ricci, Guilherme Nogueira, Michel Gardere Camargo, Maria de Lourdes Setsuko Ayrizono, João José Fagundes, Raquel Franco Leal
Format:	Article
Language:	English
Published:	Elsevier España 2019-04-01
Subjects:	Crohn’s Disease Infliximab Antibody Drug Monitoring
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322019000100216&lng=en&tlng=en